Alnylam Pharmaceuticals Stock Forecast

Sell candidate since Jul 10, 2026 Loss -6.57%

The Alnylam Pharmaceuticals stock price fell by -0.754% on the last day (Wednesday, 15th Jul 2026) from $281.26 to $279.14. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 3.25% from a day low at $275.84 to a day high of $284.80. The price has been going up and down for this period, and there has been a -7.27% loss for the last 2 weeks. Volume has increased on the last day by 192 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $355.67 million.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $275.29 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -3.02% during the next 3 months and, with a 90% probability hold a price between $266.96 and $312.92 at the end of this 3-month period.

ALNY Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Alnylam Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $300.73 and $295.52. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -13.71%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Alnylam Pharmaceuticals stock

Alnylam Pharmaceuticals finds support from accumulated volume at $278.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $8.96 between high and low, or 3.25%. For the last week, the stock has had daily average volatility of 9.26%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALNY) For The Upcoming Trading Day Of Thursday 16th

For the upcoming trading day on Thursday, 16th we expect Alnylam Pharmaceuticals to open at $279.93, and during the day (based on 14 day Average True Range), to move between $271.73 and $286.55, which gives a possible trading interval of +/-$14.81 (+/-5.45%) up or down from last closing price. If Alnylam Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 5.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $278.09 (0.38%) than the resistance at $288.06 (3.20%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Alnylam Pharmaceuticals stock A Buy?

Alnylam Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.818 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 16, 2026 - $279.93 ( 0.281%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk